Novo Nordisk Files Lawsuit Against Florida Pharmacies for Selling Impure Wegovy and Ozempic Knock-Offs

Novo Nordisk has filed a lawsuit against two compounding pharmacies in Florida, Wells Pharmacy and Brooksville Pharmaceuticals, after finding impurities in their products claiming to contain the active ingredient for its weight-loss drug Wegovy. The impurities were found to be as much as 33% in some samples, and the compounded versions of Wegovy from Brooksville were also shown to be less potent than advertised. Novo Nordisk aims to prevent the pharmacies from selling products claiming to contain semaglutide, the main ingredient in Wegovy, and to stop Wells Pharmacy from making false claims about FDA approval and the health benefits of BPC-157. Novo Nordisk has already filed multiple lawsuits against other establishments offering products claiming to contain semaglutide.